Targeted TPX2 increases chromosome missegregation and suppresses tumor cell growth in human prostate cancer
OncoTargets and Therapy Aug 22, 2017
Pan HW, et al. – In order to figure out if targeted TPX2 increased chromosome missegregation and suppressed tumor cell growth in human prostate cancer, experts performed this study. Data depicted that TPX2 as a potential novel target gene for prostate cancer treatment had power.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
